Obesity and acylcarnitine derivates interplay with coronary artery disease

Obesity and acylcarnitine derivates interplay with coronary artery disease

Abstract Coronary artery disease (CAD) is common in patients burdened with metabolic syndrome. Increased risk of cardiovascular disease is associated with abnormal levels of acylated derivates of carnitine. The present study aimed to evaluate the possible association between carnitine derivatives an...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomasz Urbanowicz, Paweł Gutaj, Szymon Plewa, Ievgen Spasenenko, Anna Olasińska-Wiśniewska, Beata Krasińska, Andrzej Tykarski, Aleksandra Krasińska-Plachta, Łucja Pilaczyńska-Szcześniak, Zbigniew Krasiński, Ewelina Grywalska, Mansur Rahnama, Jan Matysiak, Ewa Wender-Ożegowska
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Acylcarnitine
Obesity
Coronary artery disease
Online Access:https://doi.org/10.1038/s41598-025-99944-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-99944-3

Similar Items